Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05437575 · ClinicalTrials.gov registry record · Phase 3
Prehospital Analgesia INtervention Trial (PAIN)
A Phase 3 study of Traumatic Injury, sponsored by Jason Sperry.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 994
- Enrollment target
- 11
- Study locations
NCT05437575 is a Phase 3 study of Traumatic Injury that is actively recruiting participants, run by Jason Sperry. The registered enrollment target is 994 participants, above the 297-participant average among 7 other Traumatic Injury trials with a reported enrollment target (235% higher). The trial reports 11 study locations across 8 states.
The verdict
NCT05437575, a Phase 3 study of Traumatic Injury, is actively recruiting participants, sponsored by Jason Sperry.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 994 participants
- Enrollment target
- 11
- Study locations
Study Summary
The Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, interventional, randomized trial among prehospital trauma patients with compensated shock (SI≥0.9 or HR ≥115) and an indication for pain management, comparing patient centered outcomes following prehospital administration of ketamine hydrochloride versus fentanyl citrate.
Conditions Studied
Interventions
- DRUG Ketamine Hydrochloride
- DRUG Fentanyl Citrate
Study Locations (11)
Pennsylvania
- Allegheny Health Network (AHN) Allegheny General Hospital - Pittsburgh
- University of Pittsburgh - Pittsburgh
- Guthrie Robert Packer Hospital - Sayre
California
- University of California, San Diego - San Diego
- Zuckerberg San Francisco General Hospital - San Francisco
New Jersey
- Cooper University Health Care - Camden
North Carolina
- Atrium Health and Carolinas Medical Center - Charlotte
Ohio
- University of Cincinnati - Cincinnati
Utah
- University of Utah - Salt Lake City
Vermont
- The University of Vermont Larner College of Medicine - Burlington
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 994 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2029-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05437575
The ClinicalTrials.gov registry entry for NCT05437575 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 994 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 7 other Traumatic Injury trials with a reported enrollment target (235% higher). The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Injury appearing as the primary indexed condition, and to 2 interventions - of which Ketamine Hydrochloride is the first listed.
NCT05437575 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Pennsylvania, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05437575 about?
NCT05437575 is a clinical study titled "Prehospital Analgesia INtervention Trial (PAIN)". The Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, interventional, random...
What is the current status of trial NCT05437575?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 994 participants. The study started on 2023-11-27. Estimated completion is 2029-07.
What conditions does trial NCT05437575 study?
This clinical trial studies the following conditions: Traumatic Injury.
What interventions are being tested in trial NCT05437575?
The interventions under investigation include: Ketamine Hydrochloride (DRUG), Fentanyl Citrate (DRUG).
Who is sponsoring clinical trial NCT05437575?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05437575 being conducted?
This trial has 11 study locations across California, New Jersey, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DSUVIA Early Evaluation of Pain Trial
COMPLETED · Phase 3
-
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial
COMPLETED · Phase 3
-
Advancing Discussions Using a Video-based Support Tool About End-of-life Care
RECRUITING · NA
-
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
RECRUITING · NA
-
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
RECRUITING · NA
-
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.